Reliable pMDI Solutions for Respiratory Drug Delivery
Respipure offers specialized development and manufacturing capabilities for pressurized metered-dose inhalers (pMDIs), one of the most established and trusted inhalation platforms for respiratory therapies. Our integrated approach ensures consistent dose delivery, product reliability, and regulatory-ready performance.
You are here:
pMDI Expertise
pMDI Expertise
Pressurized metered-dose inhalers remain a cornerstone of respiratory drug delivery, particularly for low-dose therapies requiring rapid onset of action. Their portability, reliability, and patient familiarity make them a preferred choice for both maintenance and rescue medications.
Respipure brings focused expertise in pMDI formulation and process development, addressing critical factors such as formulation stability, valve performance, aerosol generation, and dose uniformity to deliver dependable pMDI products.
Why-Pressurized-Metered-Dose
Why Pressurized Metered-Dose Inhalers
pMDIs continue to play a vital role in respiratory care due to several key advantages:
- Proven and widely accepted inhalation platform
- Accurate delivery of low drug doses to the lungs
- Rapid onset of therapeutic action
- Compact, portable, and patient-friendly design
- Suitable for a wide range of respiratory indications
pMDI Development & Manufacturing
pMDI Development & Manufacturing
Respipure provides integrated pMDI development support, from formulation optimization to manufacturing-ready processes.
Our capabilities include:
- pMDI formulation development and optimization
- Compatibility assessment between formulation, canister, and valve systems
- Pilot-scale and scalable filling process development
- Support for next-generation, lower global warming potential (GWP) propellant transitions
- GMP-aligned manufacturing processes designed for consistency and compliance
sus
Performance, Quality & Sustainability Focus
pMDI products developed at Respipure are supported by robust analytical evaluation and quality systems to ensure consistent performance across batches.
Our approach emphasizes:
- Delivered dose consistency and aerosol performance
- Product robustness throughout shelf life
- Alignment with evolving regulatory and sustainability expectations